Form 4: Perrigo Executive Grainne Quinn Reports Stock Transactions

EVP and Chief Medical Officer of Perrigo, Grainne Quinn, reports acquisition and disposal of ordinary shares and restricted stock units.

Summary

• Grainne Quinn, EVP and Chief Medical Officer of Perrigo Company plc, reported transactions involving ordinary shares and restricted stock units.
• On March 6, 2024, Quinn acquired 1,759 ordinary shares at $28.09 and disposed of 915 shares at the same price.
• Following these transactions on March 6, Quinn directly owned 19,999 ordinary shares.
• On March 7, 2024, Quinn acquired 2,249 ordinary shares at $29.69 and disposed of 1,170 shares at the same price.
• Following these transactions on March 7, Quinn directly owned 21,078 ordinary shares.
• Quinn also reported transactions involving restricted stock units, with 3,517 and 2,249 units beneficially owned following reported transactions on March 6 and 7, 2024 respectively.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by an executive, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which is important for maintaining market confidence.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding executive compensation and stock ownership.

Key Dates